Volume 18, Number 8—August 2012
Research
VIM-2–producing Multidrug-Resistant Pseudomonas aeruginosa ST175 Clone, Spain
Esther Viedma, Carlos Juan, Jennifer Villa, Laura Barrado, M. Ángeles Orellana, Francisca Sanz, Joaquín R. Otero, Antonio Oliver, and Fernando Chaves
Table
Characteristics of 183 patients colonized or infected with clone B or nonclone B multidrug-resistant Pseudomonas isolates, Spain, January 2007–December 2010*
| Characteristic | Patients with clone B, n = 104 | Patients with non–clone B, n = 79 | p value |
|---|---|---|---|
| Mean ± SD age, y | 67.5 ± 15.4 | 61.9 ± 15.7 | 0.016 |
| Male | 74 (71.1) | 55 (69.6) | 0.822 |
| Hospital location | |||
| Surgical ward | 15 (14.4) | 17 (21.5) | 0.211 |
| Intensive care unit | 11 (10.6) | 13 (16.4) | 0.243 |
| Internal medicine ward | 39 (37.5) | 18 (22.8) | 0.033 |
| Hematology ward | 4 (3.8) | 11 (13.9) | 0.014 |
| Pulmonology ward | 17 (16.3) | 4 (5.1) | 0.018 |
| Hospitalization within previous 3 mo | 48 (46.1) | 37 (46.8) | 0.927 |
| Surgical procedure | 29 (27.9) | 32 (40.5) | 0.073 |
| Transplant | 4 (3.8) | 8 (10.1) | 0.089 |
| Hematologic malignancy | 8 (7.7) | 11(13.9) | 0.171 |
| Solid tumor | 21 (20.2) | 13 (16.4) | 0.520 |
| Diabetes mellitus | 29 (27.9) | 21 (26.9) | 0.845 |
| Chronic obstructive pulmonary disease | 38 (36.5) | 18 (22.8) | 0.046 |
| Central catheter | 83 (79.8) | 59 (76.7) | 0.410 |
| Urinary catheter | 60(57.7) | 44(55.7) | 0.441 |
| Infections | 82 (78.8) | 61 (77.2) | 0.791 |
| Respiratory tract | 25 (24) | 11 (13.9) | 0.088 |
| Intraabdominal | 7 (6.7) | 15 (19) | 0.012 |
| Wound | 4 (3.8) | 8 (10.1) | 0.089 |
| Urinary tract | 19 (18.3) | 11 (13.9) | 0.432 |
| Bacteremia | 12 (11.5) | 16 (20.2) | 0.105 |
| Died during hospitalization | 20 (19.2) | 22 (27.8) | 0.170 |
*Values are no. (%) unless otherwise indicated.
Page created: June 21, 2012
Page updated: June 21, 2012
Page reviewed: June 21, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.